The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology-Reference-Cited by-同舟云学术

The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology

Published:2023-03 Issue: Volume:13 Page:100472
ISSN:2666-6677
Container-title:American Journal of Preventive Cardiology
language:en
Short-container-title:American Journal of Preventive Cardiology

Author:

Virani Salim S.,Aspry Karen,Dixon Dave L.,Ferdinand Keith C.,Heidenreich Paul A.,Jackson Elizabeth J.,Jacobson Terry A.,McAlister Janice L.,Neff David R.,Gulati Martha,Ballantyne Christie M.

Publisher

Elsevier BV

Subject

General Medicine

Reference68 articles.

1. Heart disease and stroke statistics-2022 update: a report from the American heart association;Tsao;Circulation,2022

2. High-intensity statin use among patients with atherosclerosis in the U.S;Nelson;J Am Coll Cardiol,2022

3. Heart disease and stroke statistics—2023 update: a report from the American heart association;Tsao;Circulation,2023

4. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial;Neaton;Arch Intern Med,1992

5. Cholesterol treatment trialists' (CTT) collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials;Lancet,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond;American Journal of Preventive Cardiology;2024-09

2. Atherogenic lipid profile in patients with statin treatment after acute coronary syndrome: a real-world analysis from Chinese cardiovascular association database;Lipids in Health and Disease;2024-08-28

3. Efficacy of Alirocumab, Evolocumab, and Inclisiran in Patients with Hypercholesterolemia at Increased Cardiovascular Risk;Medicina;2024-07-12

4. Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024;Medical Clinics of North America;2024-05

5. Trends in epidemiology of dyslipidemias in India;Indian Heart Journal;2024-03